12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 200 OK [1] => Date: Thu, 09 Oct 2025 07:40:59 GMT [2] => Content-Type: text/xml; charset=utf-8 [3] => Connection: close [4] => Cache-Control: no-cache, private [5] => Cache-Control: no-cache, no-store, must-revalidate [6] => Nel: {"report_to":"cf-nel","success_fraction":0.0,"max_age":604800} [7] => x-frame-options: SAMEORIGIN [8] => x-content-type-options: nosniff [9] => x-xss-protection: 1; mode=block [10] => referrer-policy: strict-origin-when-cross-origin [11] => permissions-policy: geolocation=(), microphone=(), camera=() [12] => content-security-policy: default-src * 'unsafe-inline' 'unsafe-eval' data: blob:; script-src * 'unsafe-inline' 'unsafe-eval' data: blob:; style-src * 'unsafe-inline' data:; img-src * data: blob:; font-src * data:; connect-src *; frame-src *; object-src *; media-src *; child-src *; [13] => Server: cloudflare [14] => x-robots-tag: noindex, nofollow, nosnippet, noarchive [15] => strict-transport-security: max-age=31536000; includeSubDomains; preload [16] => expires: Fri, 10 Oct 2025 07:40:58 GMT [17] => vary: Accept-Encoding [18] => Report-To: {"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https://a.nel.cloudflare.com/report/v4?s=tO%2BhSy4%2FTY1Z0zIlgYumdHWSRIEPgAb1K6vvR5qyfc6jmvHNhuKQd2uD6aohiaBYo3uR7uvbiEk1Oj47g2%2FYKWSHB60sTTZwhEaH20Q%3D"}]} [19] => cf-cache-status: DYNAMIC [20] => Speculation-Rules: "/cdn-cgi/speculation" [21] => Server-Timing: cfCacheStatus;desc="DYNAMIC" [22] => Server-Timing: cfEdge;dur=2,cfOrigin;dur=108 [23] => Set-Cookie: UpalLiveSession=eyJpdiI6InRDQ3lOc0FzT1RKdVwvbDNkZDNlQXZ3PT0iLCJ2YWx1ZSI6InVtSVRvRXBtSnZ2WFhUd3pWRGNYczdlOHBDYWM2bnFIOVwvV2Mxa2Z4MWZOaU1PUThyMUVydFR6MllOakc3RmpjdVhBbzdGbnpaRlVGclJnSThZb1wvT3c9PSIsIm1hYyI6IjljNzBhNGQ0ZjYwZmY5OWFmOGRhYjZjODliMDQ0MGMyNTBmNWYzZmE2NDlhZDBkYmM1NWEyZmNlMDY4OTliNTEifQ%3D%3D; HttpOnly; Path=/; Max-Age=94608000; Expires=Sun, 08 Oct 2028 07:40:59 GMT [24] => CF-RAY: 98bc3ba42f73da55-KUL [25] => alt-svc: h3=":443"; ma=86400 ) 789

中国红十字基金会官网周四指出，迄今已有来自湖北、山东、四川、湖南、海南、江苏、重庆、甘肃、北京、河南、江西、吉林、上海、天津共14个省市的113名新冠肺炎康复者为“抗疫”，志愿捐献血浆。

天津市新冠肺炎康复者恢复期血浆采集周四在天津市海河医院进行，一名29岁的新冠肺炎康复者捐出400毫升“抗疫”血浆，成为天津市首名新冠肺炎康复者血浆捐献志愿者。

他向媒体表示：“我虽然不是(天津)第一个出院的，但是我希望我是(天津)第一个为疫情做贡献的！”

根据中国国家卫健委发布的《新型冠状病毒感染的肺炎诊疗方案(试行第五版)》，对重型、危重型病例的治疗可采用恢复期血浆治疗，特别是在缺乏疫苗和特效治疗药物的情况下，采用该种特免血浆制品治疗新型冠状病毒感染是最为有效的方法，可大幅降低危重患者病死率。

据悉，“抗疫”血浆捐献志愿者均为刚刚战胜新冠肺炎病魔、治愈出院的康复患者，他们捐献的血浆经过专业化处置输入危重患者体内，将产生针对新型冠状病毒的特异性抗体，可杀灭和清除病毒，这一疗法被称为“恢复期血浆治疗法”。